HomeShopTirzepatide
Vial Research Tirzepatide 30mg research vial — GLP-1 Agonists
Batch Tracked
3rd Party Tested
≥98% Purity
COA Included
GLP-1 Agonists·VR-1002

Tirzepatide 30mg

30mg
CAS2023788-19-2
glp-1gipweight-lossmetabolic
$130$600 / 5-pack

+ $9.99 flat-rate shipping

For research purposes only. Not for human consumption. Not evaluated by the FDA.

Tirzepatide is a dual GIP and GLP-1 receptor agonist investigated in research on incretin signaling, glycemic control, and body-composition pathways. Supplied as 30mg lyophilized powder, ≥98% HPLC purity, with batch-specific Certificate of Analysis. Reconstitute with bacteriostatic water. For laboratory research use only.

Incretin-class research compounds that engage GLP-1 and related receptors, widely used in studies of glucose regulation, appetite pathways, and energy metabolism.

Research Applications

Tirzepatide is used by qualified researchers to investigate pathways including:

  • Incretin-receptor signaling (GLP-1, GIP, glucagon)
  • Glucose homeostasis and insulin-secretion studies
  • Appetite-regulation and energy-balance models
  • Gastric-emptying and satiety-pathway research

Product Specifications

Product Name
Tirzepatide
SKU
VR-1002
Dosage / Size
30mg
CAS Number
2023788-19-2
Category
GLP-1 Agonists
Form
Lyophilized Powder
Storage
-20°C, protect from light
Purity
≥98% (HPLC verified)
For Use
Research & Laboratory Only

Handling & Reconstitution

Tirzepatide is supplied as lyophilized (freeze-dried) powder. For research reconstitution, inject bacteriostatic water slowly down the inner wall of the vial and swirl gently — do not shake — until fully dissolved. Typical reconstitution volume is 1–3 mL depending on the research protocol and desired working concentration. Store lyophilized product at -20 °C; store reconstituted material at 2–8 °C and use within the stability window set by your laboratory.

Quality Assurance

Every batch of Tirzepatide is analytically verified by an independent third-party laboratory for identity, purity, and potency. Certificates of Analysis are generated per batch and are accessible via the Batch Testing page or the Batch / COA tab above.

Frequently Asked Questions

How is Tirzepatide 30mg supplied and reconstituted?

Tirzepatide 30mg is supplied as a lyophilized powder in a sealed vial. For research use, reconstitute with bacteriostatic water (typically 1–3 mL depending on the research protocol) by injecting diluent slowly down the vial wall and gently swirling to dissolve. Do not shake. Store reconstituted material at 2–8 °C and use within the stability window established by your laboratory.

What purity does Vial Research guarantee for Tirzepatide?

Each batch of Tirzepatide is analytically tested by an independent third-party laboratory. Purity is verified to ≥98% (HPLC) for peptide and small-molecule products. A batch-specific Certificate of Analysis (COA) is available on every product page via the Batch / COA tab.

How is Tirzepatide stored?

Store lyophilized vials at -20 °C, protected from light. After reconstitution, store at 2–8 °C and use within the stability window established by your protocol. Avoid repeated freeze-thaw cycles.

Is Tirzepatide intended for human use?

No. Tirzepatide is sold for in-vitro and laboratory research use only by qualified researchers. It is not a drug, supplement, or consumer product and has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition.

Related Compounds